Lactobacillus plantarum DK119 as a Probiotic Confers Protection against Influenza Virus by Modulating Innate Immunity
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Lactobacillus plantarum DK119 (DK119) isolated from the fermented Korean cabbage food was used as a probiotic to determine its antiviral effects on influenza virus. DK119 intranasal or oral administration conferred 100% protection against subsequent lethal infection with influenza A viruses, prevented significant weight loss, and lowered lung viral loads in a mouse model. The antiviral protective efficacy was observed in a dose and route dependent manner of DK119 administration. Mice that were treated with DK119 showed high levels of cytokines IL-12 and IFN-γ in bronchoalveolar lavage fluids, and a low degree of inflammation upon infection with influenza virus. Depletion of alveolar macrophage cells in lungs and bronchoalveolar lavages completely abrogated the DK119-mediated protection. Modulating host innate immunity of dendritic and macrophage cells, and cytokine production pattern appeared to be possible mechanisms by which DK119 exhibited antiviral effects on influenza virus infection. These results indicate that DK119 can be developed as a beneficial antiviral probiotic microorganism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213 · cited 1×
“Influenza is a serious respiratory disease causing over 220,000 hospitalizations and approximately 36,000 annual deaths in the United States during seasonal epidemics [1].”
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
Probiotics and their fermented food products are beneficial for health
Parvez, S., Malik, K. A., Ah Kang, S., & Kim, H.-Y. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.02963.x · Cited by 1,435 · cited 1×
“Various fermented vegetables and dairy products contain a variety of lactic acid bacteria that were shown to provide health benefits and improvements to a certain level [8–11].”
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,259 · cited 1×
“A recent pandemic outbreak of the new 2009 H1N1 virus provides a good example of a limited efficacy of current vaccination [2].”
Dunne, C., O’Mahony, L., Murphy, L., Thornton, G., Morrissey, D., O’Halloran, S., Feeney, M., Flynn, S., Fitzgerald, G., Daly, C., et al. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.386s · Cited by 922 · cited 1×
“The capability of lactic acid bacterial species to grow in low pH and/or high salt conditions in fermented foods enables lactic acid bacteria to survive gastric acid in the stomach and bile acid in the intestines [12,13].”
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus
Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551 · cited 1×
“Pathogenesis of influenza virus infection is known to be involved with hyper-inflammatory responses [30,34–36].”
Tumpey, T. M., García-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Pantin-Jackwood, M. J., Schultz-Cherry, S., Solórzano, A., Van Rooijen, N., Katz, J. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14933-14944.2005 · Cited by 507 · cited 3×
“Since alveolar macrophages were reported to contribute to controlling lung viral loads and reducing mortality [30], we further hypothesized that lung airway dendritic and macrophage cells would play a vital role in conferring DK119-mediated protection against influenza virus.”
InfluentialOseltamivir Resistance — Disabling Our Influenza Defenses
Moscona, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058291 · Cited by 332
Quan, F.-S., Huang, C., Compans, R. W., & Kang, S.-M. (2007) · Journal of Virology · doi:10.1128/jvi.02052-06 · Cited by 313 · cited 3×
“5 LD50, 50% lethal dose for BALB/c mice) as described [42–45].”
Self-citationFujiwara, D., Inoue, S., Wakabayashi, H., & Fujii, T. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000081305 · Cited by 244 · cited 1×
“effects on immune diseases in mice [16,17] and humans [18,19].”
Cytokines in the pathogenesis of influenza
Van Reeth, K. (2000) · Veterinary Microbiology · doi:10.1016/s0378-1135(00)00171-1 · Cited by 232 · cited 1×
“correlated with influenza associated lethality [35,37].”
Current and future antiviral therapy of severe seasonal and avian influenza
Beigel, J., & Bray, M. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.01.003 · Cited by 232 · cited 1×
“Antiviral medications also have limitations such as immediate administration after infection, adverse reactions, and emergence of drug resistant strains [3–7].”
McGill, J., Van Rooijen, N., & Legge, K. L. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080314 · Cited by 231 · cited 2×
“It was previously reported that dendritic and macrophage cells were selectively depleted by intranasal or intratracheal administration with clodronate-liposomes [31,32].”
Makino, S., Ikegami, S., Kume, A., Horiuchi, H., Sasaki, H., & Orii, N. (2010) · British Journal of Nutrition · doi:10.1017/s000711451000173x · Cited by 231 · cited 1×
“Yogurt fermented with Lactobacillus was shown to reduce the cases of catching cold in the healthy elderly [20] and to prolong the”
Lactic Acid Bacteria and Human Health
Gorbach, S. L. (1990) · Annals of Medicine · doi:10.3109/07853899009147239 · Cited by 220 · cited 1×
“Various fermented vegetables and dairy products contain a variety of lactic acid bacteria that were shown to provide health benefits and improvements to a certain level [8–11].”
Hall, J. D., Woolard, M. D., Gunn, B. M., Craven, R. R., Taft-Benz, S., Frelinger, J. A., & Kawula, T. H. (2008) · Infection and Immunity · doi:10.1128/iai.01176-08 · Cited by 206 · cited 1×
“F4/80CD11cCD11b(2) phenotypic cells were classified as alveolar macrophages in a study of infected lungs [33].”
Wang, S., Le, T. Q., Kurihara, N., Chida, J., Cisse, Y., Yano, M., & Kido, H. (2010) · The Journal of Infectious Diseases · doi:10.1086/656044 · Cited by 195 · cited 1×
“correlated with influenza associated lethality [35,37].”
NAGAO, F., NAKAYAMA, M., MUTO, T., & OKUMURA, K. (2000) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.64.2706 · Cited by 193 · cited 1×
“effects on immune diseases in mice [16,17] and humans [18,19].”
Ishida, Y., Nakamura, F., Kanzato, H., Sawada, D., Hirata, H., Nishimura, A., Kajimoto, O., & Fujiwara, S. (2005) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(05)72714-4 · Cited by 192 · cited 1×
“effects on immune diseases in mice [16,17] and humans [18,19].”
Differential Pathogenesis of Respiratory Syncytial Virus Clinical Isolates in BALB/c Mice
Stokes, K. L., Chi, M. H., Sakamoto, K., Newcomb, D. C., Currier, M. G., Huckabee, M. M., Lee, S., Goleniewska, K., Pretto, C., Williams, J. V., et al. (2011) · Journal of Virology · doi:10.1128/jvi.01693-10 · Cited by 187
Harata, G., He, F., Hiruta, N., Kawase, M., Kubota, A., Hiramatsu, M., & Yausi, H. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02844.x · Cited by 186 · cited 3×
“In previous studies reporting antiviral protection, mice treated with different strains of Lactobacillus exhibited prolonged survival periods without protection [22,23] or were only partially protected after lethal infection [25–27], but illness has not been reported.”
Maeda, N., Nakamura, R., Hirose, Y., Murosaki, S., Yamamoto, Y., Kase, T., & Yoshikai, Y. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.04.015 · Cited by 179 · cited 1×
“In previous studies reporting antiviral protection, mice treated with different strains of Lactobacillus exhibited prolonged survival periods without protection [22,23] or were only partially protected after lethal infection [25–27], but illness has not been reported.”
Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
Song, J.-M., Wang, B.-Z., Park, K.-M., Van Rooijen, N., Quan, F.-S., Kim, M.-C., Jin, H.-T., Pekosz, A., Compans, R. W., & Kang, S.-M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014538 · Cited by 175 · cited 4×
“5 LD50, 50% lethal dose for BALB/c mice) as described [42–45].”
InfluentialSelf-citationNagai, T., Makino, S., Ikegami, S., Itoh, H., & Yamada, H. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.09.012 · Cited by 172 · cited 1×
“survival periods of mice with influenza virus infection [21].”
Yasui, H., Kiyoshima, J., & Hori, T. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.4.675-679.2004 · Cited by 157 · cited 3×
“In previous studies reporting antiviral protection, mice treated with different strains of Lactobacillus exhibited prolonged survival periods without protection [22,23] or were only partially protected after lethal infection [25–27], but illness has not been reported.”
Weiss, G., Rasmussen, S., Zeuthen, L. H., Nielsen, B. N., Jarmer, H., Jespersen, L., & Frøkiær, H. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03301.x · Cited by 156 · cited 1×
“Lactobacillus was also shown to induce the production of Th1 polarizing cytokine IL-12 by stimulating murine dendritic cells via Toll-like receptor-2-dependent mechanism [40].”
Youn, H.-N., Lee, D., Lee, Y., Park, J.-K., Yuk, S., Yang, S.-Y., Lee, H., Woo, S.-H., Kim, H., Lee, J., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.11.004 · Cited by 149 · cited 3×
“It was recently demonstrated that various Lactobacillus species showed differential protective efficacies with a wide range of 0–100% survival rates against influenza virus infection depending on administration routes and doses [15].”
Self-citationIzumo, T., Maekawa, T., Ida, M., Noguchi, A., Kitagawa, Y., Shibata, H., Yasui, H., & Kiso, Y. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.012 · Cited by 148 · cited 2×
“Similarly, intranasal administration of Lactobacillus pentosus strain was previously reported to induce Th1 like cytokines IL-12 and IFNc possibly contributing to host resistance to influenza infection [28].”
Hori, T., Kiyoshima‐Shibata, J., Shida, K., & Yasui, H. (2001) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.3.593-597.2001 · Cited by 147 · cited 3×
“In previous studies reporting antiviral protection, mice treated with different strains of Lactobacillus exhibited prolonged survival periods without protection [22,23] or were only partially protected after lethal infection [25–27], but illness has not been reported.”
Hori, T., Kiyoshima, J., Shida, K., & Yasui, H. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.1.105-108.2002 · Cited by 145 · cited 1×
“particular, previous studies demonstrated the protective effects on subsequent influenza virus infection by administration of various lactic acid bacterial strains via the oral route [22–25] or the”
Murawski, M. R., McGinnes, L. W., Finberg, R. W., Kurt‐Jones, E. A., Massare, M. J., Smith, G., Heaton, P. M., Fraire, A. E., & Morrison, T. G. (2009) · Journal of Virology · doi:10.1128/jvi.01709-09 · Cited by 140
Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses
Kawashima, T., Hayashi, K., Kosaka, A., Kawashima, M., Igarashi, T., Tsutsui, H., Tsuji, N. M., Nishimura, I., Hayashi, T., & Obata, A. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.08.013 · Cited by 139 · cited 1×
“Consistent with results in this study, oral administration of Lactobacillus plantarum strain was shown to enhance the production of Th1 type cytokine IFN-c in response to ovalbumin immunization [38].”
Immunostimulatory effects of fucoidan on bone marrow-derived dendritic cells
Kim, M.-H., & Joo, H.-G. (2008) · Immunology Letters · doi:10.1016/j.imlet.2007.10.016 · Cited by 123 · cited 1×
“Dendritic cells (BMDCs) were generated from bone marrow of BALB/c mice [52–54].”
Self-citationKobayashi, N., Saito, T., Uematsu, T., Kishi, K., Toba, M., Kohda, N., & Suzuki, T. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.019 · Cited by 123 · cited 1×
“In previous studies reporting antiviral protection, mice treated with different strains of Lactobacillus exhibited prolonged survival periods without protection [22,23] or were only partially protected after lethal infection [25–27], but illness has not been reported.”
Evrard, B., Coudeyras, S., Dosgilbert, A., Charbonnel, N., Alamé, J., Tridon, A., & Forestier, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018735 · Cited by 120 · cited 12×
“Levels of cytokines IFN-c and IL-12 were found to be elevated in BALF from mice orally or intranasally treated with DK119 compared to those from mice that were infected with influenza virus without DK119 (Fig 8D, E).”
InfluentialCorr, S. C., Gahan, C. G. M., & Hill, C. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00264.x · Cited by 117 · cited 1×
“against infectious diseases [14,15], and have the anti-allergic”
Phenotypic and molecular characterization of Lactococcus lactis from milk and plants
Nomura, M., Kobayashi, M., Narita, T., Kimoto-Nira, H., & Okamoto, T. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.02949.x · Cited by 116 · cited 1×
“The capability of lactic acid bacterial species to grow in low pH and/or high salt conditions in fermented foods enables lactic acid bacteria to survive gastric acid in the stomach and bile acid in the intestines [12,13].”
Thepen, T., McMenamin, C., Oliver, J., Kraal, G., & Holt, P. G. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211128 · Cited by 106 · cited 1×
“Four hours prior to infection with influenza virus A/Philippines/82 (H3N2), a group of DK119treated mice (n = 6 BALB/c) was intranasally administered clodronate-liposomes (100 ml per mouse) to deplete dendritic and macrophage cells [31,32,48].”
Immunomodulatory Activity of Ginsan, a Polysaccharide of Panax Ginseng, on Dendritic Cells
Kim, M., Byon, Y.-Y., Ko, E., Song, J., Yun, Y., Shin, T., & Joo, H. (2009) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2009.13.3.169 · Cited by 99 · cited 1×
“Dendritic cells (BMDCs) were generated from bone marrow of BALB/c mice [52–54].”
Self-citationPotential and Opportunities for Use of Recombinant Lactic Acid Bacteria in Human Health
Hanniffy, S. B., Wiedermann, U., Repa, A., Mercenier, A., Daniel, C., Fioramonti, J., Tlaskolova, H., Kozáková, H., Israelsen, H., Madsen, S. M., et al. (2004) · Advances in applied microbiology · doi:10.1016/s0065-2164(04)56001-x · Cited by 92 · cited 1×
“Various fermented vegetables and dairy products contain a variety of lactic acid bacteria that were shown to provide health benefits and improvements to a certain level [8–11].”
Mok, H., Lee, S., Utley, T. J., Shepherd, B. E., Polosukhin, V. V., Collier, M. L., Davis, N. L., Johnston, R. E., & Crowe, J. E. (2007) · Journal of Virology · doi:10.1128/jvi.01351-07 · Cited by 75
Masuda, S., Yamaguchi, H., Kurokawa, T., Shirakami, T., Tsuji, R. F., & Nishimura, I. (2007) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2007.10.011 · Cited by 60 · cited 1×
“effects on immune diseases in mice [16,17] and humans [18,19].”
Antivirals for the treatment and prevention of epidemic and pandemic influenza
OXFORD, J. S. (2007) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2006.00006.x · Cited by 49 · cited 1×
“Antiviral medications also have limitations such as immediate administration after infection, adverse reactions, and emergence of drug resistant strains [3–7].”
Effets des bact�ries lactiques ing�r�es avec des laits ferment�s sur la sant�
Drouault, S., & Corthier, G. (2001) · Veterinary Research · doi:10.1051/vetres:2001115 · Cited by 48 · cited 1×
“Various fermented vegetables and dairy products contain a variety of lactic acid bacteria that were shown to provide health benefits and improvements to a certain level [8–11].”
Cho, Y.-H., Hong, S.-M., & Kim, C.-H. (2013) · Korean Journal for Food Science of Animal Resources · doi:10.5851/kosfa.2013.33.1.75 · Cited by 39 · cited 2×
“Lactobacillus plantarum DK119 was suggested to be a promising strain as probiotics because it showed tolerance to acid and bile salt [41].”
Self-citationAltered maturation of dendritic cells by taxol, an anticancer drug
Joo, H. G. (2003) · Journal of Veterinary Science · doi:10.4142/jvs.2003.4.3.229 · Cited by 34 · cited 1×
“Dendritic cells (BMDCs) were generated from bone marrow of BALB/c mice [52–54].”
Youn, H.-N., Lee, Y.-N., Lee, D., Park, J.-K., Yuk, S., Lee, H.-J., Yeo, J.-M., Yang, S.-J., Lee, J.-B., Park, S.-Y., et al. (2012) · Poultry Science · doi:10.3382/ps.2012-02334 · Cited by 22 · cited 1×
“to provide survival benefits after influenza virus infection [15,29].”
Self-citationSafety of neuraminidase inhibitors for influenza
Jones, M., & Mar, C. D. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.5.603 · Cited by 15 · cited 1×
“Antiviral medications also have limitations such as immediate administration after infection, adverse reactions, and emergence of drug resistant strains [3–7].”
Cited by
The influence of the microbiome on respiratory health
Wypych, T. P., Wickramasinghe, L. C., & Marsland, B. J. (2019) · Nature Immunology · doi:10.1038/s41590-019-0451-9 · Cited by 611
The role of the lung microbiota and the gut–lung axis in respiratory infectious diseases
Dumas, A., Bernard, L., Poquet, Y., Lugo-Villarino, G., & Neyrolles, O. (2018) · Cellular Microbiology · doi:10.1111/cmi.12966 · Cited by 444
The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19
Olaimat, A. N., Aolymat, I., Al-Holy, M., Ayyash, M., Abu Ghoush, M., Al-Nabulsi, A. A., Osaili, T., Apostolopoulos, V., Liu, S.-Q., & Shah, N. P. (2020) · npj Science of Food · doi:10.1038/s41538-020-00078-9 · Cited by 214
Lactiplantibacillus plantarum–Nomad and Ideal Probiotic
Fidanza, M., Panigrahi, P., & Kollmann, T. R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.712236 · Cited by 180
Kanauchi, O., Andoh, A., AbuBakar, S., & Yamamoto, N. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666180116163411 · Cited by 168
“Probiotics act on both the innate and acquired immune systems and have the potency to decrease the severity of infections in the gastrointestinal [30] and upper respiratory tracts [13, 31] .”
Background
Metadata
- Authors
- Park, M.-K., NGO, V., Kwon, Y.-M., Lee, Y.-T., Yoo, S., Cho, Y.-H., Hong, S.-M., Hwang, H. S., Ko, E.-J., Jung, Y.-J., Moon, D.-W., Jeong, E.-J., Kim, M.-C., Lee, Y.-N., Jang, J.-H., Oh, J.-S., Kim, C.-H., & Kang, S.-M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-04
- Volume
- 8
- Issue
- 10
- Pages
- e75368
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2051988792
- Cited by
- 174
- References
- 49
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.